Development Of An Activity Index For Localized Scleroderma (Morphea).
Posted 02 September 2011 - 11:43 PM
This pilot study provided evidence that a combined therapy of methotrexate and low dose steroids may be effective to treat morphea. Further studies on larger cohort of patients are needed to validate this activity index. E. Lanciano. EULAR 2011 FR10406. Ann rheumatologist Dis 2011;70(Suppl3):481. (Also see: Morphea)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)